These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunological effectiveness of a 2d revaccination against diphtheria performed at intervals extended up to 7-10 years]. Maksimova NM, Sukhorukova NL, Finkel' MP. Zh Mikrobiol Epidemiol Immunobiol; 1987 May; (5):50-4. PubMed ID: 3497501 [Abstract] [Full Text] [Related]
3. [The epidemic process of diphtheria and pertussis with active immunization of a pediatric population]. Blinova LL. Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):30-1. PubMed ID: 2879404 [Abstract] [Full Text] [Related]
4. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine. Habbu MK, Poonawalla CS, Parvatikar MS, Jadhav SS. Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394 [No Abstract] [Full Text] [Related]
7. Immunity and immunization of children against diphtheria in Sweden. Mark A, Christenson B, Granström M, Strandell A, Wickbom B, Böttiger M. Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):214-9. PubMed ID: 2496989 [Abstract] [Full Text] [Related]
8. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis]. Vodicková M, Svandová E. Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973 [No Abstract] [Full Text] [Related]
12. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children. Pichichero ME, Badgett JT, Rodgers GC, McLinn S, Trevino-Scatterday B, Nelson JD. Pediatr Infect Dis J; 1987 Apr 01; 6(4):352-63. PubMed ID: 3495775 [Abstract] [Full Text] [Related]
13. [Immunological effectiveness of secondary revaccination against tetanus performed at prolonged intervals]. Maksimova NM, Basova NN, Sukhorukova NL, Finkel' MP. Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun 01; (6):43-6. PubMed ID: 3307239 [Abstract] [Full Text] [Related]
14. Antibody response to measles vaccine with DTPP. John TJ, Selvakumar R, Balrai V, Simoes EA. Am J Dis Child; 1987 Jan 01; 141(1):14. PubMed ID: 3491536 [No Abstract] [Full Text] [Related]
15. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series. Pichichero ME, Barkin RM, Samuelson JS. Pediatr Infect Dis; 1986 Jan 01; 5(4):428-30. PubMed ID: 3487779 [Abstract] [Full Text] [Related]
16. Need for new strategies for an old, persistent disease. St Geme JW, Barraff LJ. J Pediatr; 1985 Aug 01; 107(2):245-6. PubMed ID: 3874944 [No Abstract] [Full Text] [Related]
17. What is 'significant' and DTP reactions. Pediatrics; 1988 Jun 01; 81(6):912-3. PubMed ID: 3259310 [No Abstract] [Full Text] [Related]
18. [Intracutaneous test with tetanus toxoid--a possibility for evaluating cellular immune reaction]. Schöntube M, Thilo W, Schmitz HH. Padiatr Grenzgeb; 1986 Jun 01; 25(2-3):275-81. PubMed ID: 3487763 [No Abstract] [Full Text] [Related]
20. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis). Lau RC. Epidemiol Infect; 1988 Oct 01; 101(2):405-10. PubMed ID: 2903065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]